{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "23275341", "DateCompleted": {"Year": "2013", "Month": "04", "Day": "29"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1074/jbc.M112.438440"], "ArticleDate": [{"Year": "2012", "Month": "12", "Day": "28"}], "Journal": {"ISSN": "1083-351X", "JournalIssue": {"Volume": "288", "Issue": "7", "PubDate": {"Year": "2013", "Month": "Feb", "Day": "15"}}, "Title": "The Journal of biological chemistry", "ISOAbbreviation": "J Biol Chem"}, "ArticleTitle": "NADPH:quinone oxidoreductase 1 regulates host susceptibility to ozone via isoprostane generation.", "Pagination": {"StartPage": "4681", "EndPage": "4691", "MedlinePgn": "4681-91"}, "Abstract": {"AbstractText": ["NADPH:quinone oxidoreductase 1 (NQO1) is recognized as a major susceptibility gene for ozone-induced pulmonary toxicity. In the absence of NQO1 as can occur by genetic mutation, the human airway is protected from harmful effects of ozone. We recently reported that NQO1-null mice are protected from airway hyperresponsiveness and pulmonary inflammation following ozone exposure. However, NQO1 regenerates intracellular antioxidants and therefore should protect the individual from oxidative stress. To explain this paradox, we tested whether in the absence of NQO1 ozone exposure results in increased generation of A(2)-isoprostane, a cyclopentenone isoprostane that blunts inflammation. Using GC-MS, we found that NQO1-null mice had greater lung tissue levels of D(2)- and E(2)-isoprostanes, the precursors of J(2)- and A(2)-isoprostanes, both at base line and following ozone exposure compared with congenic wild-type mice. We confirmed in primary cultures of normal human bronchial epithelial cells that A(2)-isoprostane inhibited ozone-induced NF-\u03baB activation and IL-8 regulation. Furthermore, we determined that A(2)-isoprostane covalently modified the active Cys(179) domain in inhibitory \u03baB kinase in the presence of ozone in vitro, thus establishing the biochemical basis for A(2)-isoprostane inhibition of NF-\u03baB. Our results demonstrate that host factors may regulate pulmonary susceptibility to ozone by regulating the generation of A(2)-isoprostanes in the lung. These observations provide the biochemical basis for the epidemiologic observation that NQO1 regulates pulmonary susceptibility to ozone."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pediatric Pulmonary and Sleep Medicine, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA."}], "Identifier": [], "LastName": "Kummarapurugu", "ForeName": "Apparao B", "Initials": "AB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fischer", "ForeName": "Bernard M", "Initials": "BM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zheng", "ForeName": "Shuo", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Milne", "ForeName": "Ginger L", "Initials": "GL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ghio", "ForeName": "Andrew J", "Initials": "AJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Potts-Kant", "ForeName": "Erin N", "Initials": "EN"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Foster", "ForeName": "W Michael", "Initials": "WM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Soderblom", "ForeName": "Erik J", "Initials": "EJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Dubois", "ForeName": "Laura G", "Initials": "LG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Moseley", "ForeName": "M Arthur", "Initials": "MA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Thompson", "ForeName": "J Will", "Initials": "JW"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Voynow", "ForeName": "Judith A", "Initials": "JA"}], "GrantList": [{"GrantID": "R01 ES016836", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Biol Chem", "NlmUniqueID": "2985121R", "ISSNLinking": "0021-9258"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Interleukin-8"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoprostanes"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "EC 1.6.5.2", "NameOfSubstance": "NAD(P)H Dehydrogenase (Quinone)"}, {"RegistryNumber": "EC 1.6.5.2", "NameOfSubstance": "NQO1 protein, human"}, {"RegistryNumber": "EC 1.6.5.2", "NameOfSubstance": "Nqo1 protein, mouse"}, {"RegistryNumber": "K848JZ4886", "NameOfSubstance": "Cysteine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["genetics"], "DescriptorName": "Cysteine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Inflammation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-8"}, {"QualifierName": ["chemistry"], "DescriptorName": "Isoprostanes"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Lung"}, {"QualifierName": ["methods"], "DescriptorName": "Mass Spectrometry"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Models, Biological"}, {"QualifierName": ["metabolism", "physiology"], "DescriptorName": "NAD(P)H Dehydrogenase (Quinone)"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": [], "DescriptorName": "Oxidation-Reduction"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ozone"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "(1996) Health effects of outdoor air pollution. Part 2. Committee of the Environmental and Occupational Health Assembly of the American Thoracic Society. Am. J. Respir. Crit. Care Med. 153, 477\u2013498", "ArticleIdList": ["8564086"]}, {"Citation": "Peden D. B. (2005) The epidemiology and genetics of asthma risk associated with air pollution. J. Allergy Clin. Immunol. 115, 213\u2013219", "ArticleIdList": ["15696070"]}, {"Citation": "Trasande L., Thurston G. D. (2005) The role of air pollution in asthma and other pediatric morbidities. J. Allergy Clin. Immunol. 115, 689\u2013699", "ArticleIdList": ["15805986"]}, {"Citation": "Foster W. M., Brown R. H., Macri K., Mitchell C. S. (2000) Bronchial reactivity of healthy subjects: 18\u201320 h postexposure to ozone. J. Appl. Physiol. 89, 1804\u20131810", "ArticleIdList": ["11053329"]}, {"Citation": "Leikauf G. D., Simpson L. G., Santrock J., Zhao Q., Abbinante-Nissen J., Zhou S., Driscoll K. E. (1995) Airway epithelial cell responses to ozone injury. Environ. Health Perspect. 103, Suppl. 2, 91\u201395", "ArticleIdList": ["PMC1518831", "7614953"]}, {"Citation": "Pryor W. A., Squadrito G. L., Friedman M. (1995) The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic. Biol. Med. 19, 935\u2013941", "ArticleIdList": ["8582671"]}, {"Citation": "Jaspers I., Flescher E., Chen L. C. (1997) Ozone-induced IL-8 expression and transcription factor binding in respiratory epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 272, L504\u2013L511", "ArticleIdList": ["9124608"]}, {"Citation": "Nichols B. G., Woods J. S., Luchtel D. L., Corral J., Koenig J. Q. (2001) Effects of ozone exposure on nuclear factor-\u03baB activation and tumor necrosis factor-\u03b1 expression in human nasal epithelial cells. Toxicol. Sci. 60, 356\u2013362", "ArticleIdList": ["11248148"]}, {"Citation": "Fakhrzadeh L., Laskin J. D., Laskin D. L. (2004) Ozone-induced production of nitric oxide and TNF-\u03b1 and tissue injury are dependent on NF-\u03baB p50. Am. J. Physiol. 287, L279\u2013285", "ArticleIdList": ["15064226"]}, {"Citation": "Kafoury R. M., Hernandez J. M., Lasky J. A., Toscano W. A., Jr., Friedman M. (2007) Activation of transcription factor IL-6 (NF-IL-6) and nuclear factor-\u03baB (NF-\u03baB) by lipid ozonation products is crucial to interleukin-8 gene expression in human airway epithelial cells. Environ. Toxicol. 22, 159\u2013168", "ArticleIdList": ["17366569"]}, {"Citation": "Janssen-Heininger Y. M., Poynter M. E., Aesif S. W., Pantano C., Ather J. L., Reynaert N. L., Ckless K., Anathy V., van der Velden J., Irvin C. G., van der Vliet A. (2009) Nuclear factor \u03baB, airway epithelium, and asthma: avenues for redox control. Proc. Am. Thorac. Soc. 6, 249\u2013255", "ArticleIdList": ["PMC2677399", "19387025"]}, {"Citation": "Devlin R. B., McKinnon K. P., Noah T., Becker S., Koren H. S. (1994) Ozone-induced release of cytokines and fibronectin by alveolar macrophages and airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 266, L612\u2013L619", "ArticleIdList": ["8023949"]}, {"Citation": "Rusznak C., Devalia J. L., Sapsford R. J., Davies R. J. (1996) Ozone-induced mediator release from human bronchial epithelial cells in vitro and the influence of nedocromil sodium. Eur. Respir. J. 9, 2298\u20132305", "ArticleIdList": ["8947075"]}, {"Citation": "Bayram H., Sapsford R. J., Abdelaziz M. M., Khair O. A. (2001) Effect of ozone and nitrogen dioxide on the release of proinflammatory mediators from bronchial epithelial cells of nonatopic nonasthmatic subjects and atopic asthmatic patients in vitro. J. Allergy Clin. Immunol. 107, 287\u2013294", "ArticleIdList": ["11174195"]}, {"Citation": "Corradi M., Alinovi R., Goldoni M., Vettori M., Folesani G., Mozzoni P., Cavazzini S., Bergamaschi E., Rossi L., Mutti A. (2002) Biomarkers of oxidative stress after controlled human exposure to ozone. Toxicol. Lett. 134, 219\u2013225", "ArticleIdList": ["12191881"]}, {"Citation": "Bergamaschi E., De Palma G., Mozzoni P., Vanni S., Vettori M. V., Broeckaert F., Bernard A., Mutti A. (2001) Polymorphism of quinone-metabolizing enzymes and susceptibility to ozone-induced acute effects. Am. J. Respir. Crit. Care Med. 163, 1426\u20131431", "ArticleIdList": ["11371413"]}, {"Citation": "Siegel D., Franklin W. A., Ross D. (1998) Immunohistochemical detection of NADPH:quinone oxidoreductase in human lung and lung tumors. Clin. Can. Res. 4, 2065\u20132070", "ArticleIdList": ["9748120"]}, {"Citation": "Ross D., Kepa J. K., Winski S. L., Beall H. D., Anwar A., Siegel D. (2000) NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem. Biol. Interact. 129, 77\u201397", "ArticleIdList": ["11154736"]}, {"Citation": "Ross D., Siegel D. (2004) NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods Enzymol. 382, 115\u2013144", "ArticleIdList": ["15047100"]}, {"Citation": "David G. L., Romieu I., Sienra-Monge J. J., Collins W. J., Ramirez-Aguilar M., del Rio-Navarro B. E., Reyes-Ruiz N. I., Morris R. W., Marzec J. M., London S. J. (2003) Nicotinamide adenine dinucleotide (phosphate) reduced:quinone oxidoreductase and glutathione S-transferase M1 polymorphisms and childhood asthma. Am. J. Respir. Crit. Care Med. 168, 1199\u20131204", "ArticleIdList": ["12969868"]}, {"Citation": "Chen C., Arjomandi M., Tager I. B., Holland N., Balmes J. R. (2007) Effects of antioxidant enzyme polymorphisms on ozone-induced lung function changes. Eur. Respir. J. 30, 677\u2013683", "ArticleIdList": ["PMC3282174", "17652311"]}, {"Citation": "Voynow J. A., Fischer B. M., Zheng S., Potts E. N., Grover A. R., Jaiswal A. K., Ghio A. J., Foster W. M. (2009) NAD(P)H quinone oxidoreductase 1 is essential for ozone-induced oxidative stress in mice and humans. Am. J. Respir. Cell Mol. Biol. 41, 107\u2013113", "ArticleIdList": ["PMC2701957", "19059883"]}, {"Citation": "Reich E. E., Markesbery W. R., Roberts L. J., 2nd, Swift L. L., Morrow J. D., Montine T. J. (2001) Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. Am. J. Pathol. 158, 293\u2013297", "ArticleIdList": ["PMC1850257", "11141503"]}, {"Citation": "Morrow J. D., Roberts L. J., Daniel V. C., Awad J. A., Mirochnitchenko O., Swift L. L., Burk R. F. (1998) Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo\u2014effects of oxygen tension and glutathione. Arch. Biochem. Biophys. 353, 160\u2013171", "ArticleIdList": ["9578611"]}, {"Citation": "Musiek E. S., Gao L., Milne G. L., Han W., Everhart M. B., Wang D., Backlund M. G., DuBois R. N., Zanoni G., Vidari G., Blackwell T. S., Morrow J. D. (2005) Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages. J. Biol. Chem. 280, 35562\u201335570", "ArticleIdList": ["16100121"]}, {"Citation": "Lappas M., Permezel M., Holdsworth S. J., Zanoni G., Porta A., Rice G. E. (2007) Antiinflammatory effects of the cyclopentenone isoprostane 15-A2-IsoP in human gestational tissues. Free Radic. Biol. Med. 42, 1791\u20131796", "ArticleIdList": ["17512458"]}, {"Citation": "Krunkosky T. M., Martin L. D., Fischer B. M., Voynow J. A., Adler K. B. (2003) Effects of TNF\u03b1 on expression of ICAM-1 in human airway epithelial cells in vitro: oxidant-mediated pathways and transcription factors. Free Rad. Biol. Med. 35, 1158\u20131167", "ArticleIdList": ["14572618"]}, {"Citation": "Zheng S., Byrd A. S., Fischer B. M., Grover A. R., Ghio A. J., Voynow J. A. (2007) Regulation of MUC5AC expression by NAD(P)H:quinone oxidoreductase 1. Free Radic. Biol. Med. 42, 1398\u20131408", "ArticleIdList": ["PMC1913945", "17395013"]}, {"Citation": "Awad J. A., Morrow J. D., Takahashi K., Roberts L. J., 2nd. (1993) Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma. J. Biol. Chem. 268, 4161\u20134169", "ArticleIdList": ["8440704"]}, {"Citation": "Voynow J. A., Fischer B. M., Malarkey D. E., Burch L. H., Wong T., Longphre M., Ho S. B., Foster W. M. (2004) Neutrophil elastase induces mucus cell metaplasia in mouse lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 287, L1293\u2013L1302", "ArticleIdList": ["15273079"]}, {"Citation": "Reynaert N. L., van der Vliet A., Guala A. S., McGovern T., Hristova M., Pantano C., Heintz N. H., Heim J., Ho Y. S., Matthews D. E., Wouters E. F., Janssen-Heininger Y. M. (2006) Dynamic redox control of NF-\u03baB through glutaredoxin-regulated S-glutathionylation of inhibitory \u03baB kinase \u03b2. Proc. Natl. Acad. Sci. U.S.A. 103, 13086\u201313091", "ArticleIdList": ["PMC1559757", "16916935"]}, {"Citation": "Musiek E. S., Yin H., Milne G. L., Morrow J. D. (2005) Recent advances in the biochemistry and clinical relevance of the isoprostane pathway. Lipids 40, 987\u2013994", "ArticleIdList": ["16382569"]}, {"Citation": "Farias S. E., Heidenreich K. A., Wohlauer M. V., Murphy R. C., Moore E. E. (2011) Lipid mediators in cerebral spinal fluid of traumatic brain injured patients. J. Trauma 71, 1211\u20131218", "ArticleIdList": ["21427623"]}, {"Citation": "Farias S. E., Basselin M., Chang L., Heidenreich K. A., Rapoport S. I., Murphy R. C. (2008) Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain. J. Lipid Res. 49, 1990\u20132000", "ArticleIdList": ["PMC2515526", "18503030"]}, {"Citation": "Pantano C., Reynaert N. L., van der Vliet A., Janssen-Heininger Y. M. (2006) Redox-sensitive kinases of the nuclear factor-\u03baB signaling pathway. Antioxid. Redox. Signal. 8, 1791\u20131806", "ArticleIdList": ["16987032"]}, {"Citation": "Schreck R., Rieber P., Baeuerle P. A. (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-\u03baB transcription factor and HIV-1. EMBO J. 10, 2247\u20132258", "ArticleIdList": ["PMC452914", "2065663"]}, {"Citation": "Valacchi G., Pagnin E., Phung A., Nardini M., Schock B. C., Cross C. E., van der Vliet A. (2005) Inhibition of NF\u03baB activation and IL-8 expression in human bronchial epithelial cells by acrolein. Antioxid. Redox. Signal. 7, 25\u201331", "ArticleIdList": ["15650393"]}, {"Citation": "Kapahi P., Takahashi T., Natoli G., Adams S. R., Chen Y., Tsien R. Y., Karin M. (2000) Inhibition of NF-\u03baB activation by arsenite through reaction with a critical cysteine in the activation loop of I\u03baB kinase. J. Biol. Chem. 275, 36062\u201336066", "ArticleIdList": ["10967126"]}, {"Citation": "Ahmad R., Raina D., Meyer C., Kharbanda S., Kufe D. (2006) Triterpenoid CDDO-Me blocks the NF-\u03baB pathway by direct inhibition of IKK\u03b2 on Cys-179. J. Biol. Chem. 281, 35764\u201335769", "ArticleIdList": ["16998237"]}, {"Citation": "Gupta S. C., Prasad S., Reuter S., Kannappan R., Yadav V. R., Ravindran J., Hema P. S., Chaturvedi M. M., Nair M., Aggarwal B. B. (2010) Modification of cysteine 179 of I\u03baB\u03b1 kinase by nimbolide leads to down-regulation of NF-\u03baB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents. J. Biol. Chem. 285, 35406\u201335417", "ArticleIdList": ["PMC2975164", "20829362"]}, {"Citation": "Son P. S., Park S. A., Na H. K., Jue D. M., Kim S., Surh Y. J. (2010) Piceatannol, a catechol-type polyphenol, inhibits phorbol ester-induced NF-\u03baB activation and cyclooxygenase-2 expression in human breast epithelial cells: cysteine 179 of IKK\u03b2 as a potential target. Carcinogenesis 31, 1442\u20131449", "ArticleIdList": ["20584749"]}, {"Citation": "Harikumar K. B., Kunnumakkara A. B., Ahn K. S., Anand P., Krishnan S., Guha S., Aggarwal B. B. (2009) Modification of the cysteine residues in I\u03baB\u03b1 kinase and NF-\u03baB (p65) by xanthohumol leads to suppression of NF-\u03baB-regulated gene products and potentiation of apoptosis in leukemia cells. Blood 113, 2003\u20132013", "ArticleIdList": ["PMC2947354", "18952893"]}, {"Citation": "Rossi A., Kapahi P., Natoli G., Takahashi T., Chen Y., Karin M., Santoro M. G. (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of I\u03baB kinase. Nature 403, 103\u2013108", "ArticleIdList": ["10638762"]}, {"Citation": "Janssen L. J., Catalli A., Helli P. (2005) The pulmonary biology of isoprostanes. Antioxid. Redox. Signal. 7, 244\u2013255", "ArticleIdList": ["15650412"]}, {"Citation": "Milne G. L., Musiek E. S., Morrow J. D. (2005) F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 10, Suppl. 1, S10\u2013S23", "ArticleIdList": ["16298907"]}, {"Citation": "Janssen L. J. (2001) Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L1067\u2013L1082", "ArticleIdList": ["11350785"]}, {"Citation": "Milne G. L., Musiek E. S., Morrow J. D. (2005) The cyclopentenone (A2/J2) isoprostanes\u2014unique, highly reactive products of arachidonate peroxidation. Antioxid. Redox. Signal. 7, 210\u2013220", "ArticleIdList": ["15650409"]}]}], "History": [{"Year": "2013", "Month": "1", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2013", "Month": "1", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2013", "Month": "4", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2014", "Month": "2", "Day": "15"}], "PublicationStatus": "ppublish", "ArticleIdList": ["23275341", "PMC3576073", "10.1074/jbc.M112.438440", "S0021-9258(20)46271-4"]}}], "PubmedBookArticle": []}